Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 367 (ZNF367) is a member of the C2H2 zinc finger protein superfamily and functions as a DNA-binding transcription factor that regulates gene expression via RNA polymerase II. It is primarily located in the nucleus and is expressed in various tissues, notably in the brain and retina. ZNF367 plays important roles in neurogenesis, neuronal differentiation, and cell cycle control, particularly controlling the metaphase-to-anaphase transition and maintaining chromosome stability. Knockdown studies in vertebrates show that ZNF367 is essential for proper cell cycle exit and neuronal differentiation but is not involved in the initial specification of neurons. Dysregulation of ZNF367 has been implicated in cancer progression and neurodevelopmental disorders, but as of September 2025, it is not a direct therapeutic target nor are there drugs known to interact with it or exploit its mechanisms of action[1][2][3][5][9].
None directly established — it functions by regulating transcription and cell cycle; mechanisms for drugs have not been identified in the literature
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 367 (ZNF367).